The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Written By Medius Associates
15 November 2018
There was much speculation last year that the US tax cuts that favoured the...
This issue of Deal Watch focuses on deal activities during the months of Ju...
June has proved to be a very busy month on the deal front with significant ...
This month’s top deals are noticeably in the category of acquisitions rathe...
How the pharmaceutical industry is changing - where has it come from, where...
Are we on trend this spring? Just when Medius’ predictions for 2018 indicat...
February may be the shortest month, but companies have managed to pack plen...
One key question for 2018 is whether the recent US tax changes will have an...
In looking at deals each month, certain patterns start to emerge. This mon...
The LSX Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
LSX is an influential community of senior life science decision makers.
We connect senior biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
LSX Nordic Congress: Virtual
Healthtech Leaders: Virtual
LSX USA CEO Forums: Virtual
European Lifestars Awards
LSX World Congress